chr1-15727567-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015164.4(PLEKHM2):c.1495G>T(p.Ala499Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000393 in 1,575,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015164.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEKHM2 | NM_015164.4 | c.1495G>T | p.Ala499Ser | missense_variant | 9/20 | ENST00000375799.8 | NP_055979.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEKHM2 | ENST00000375799.8 | c.1495G>T | p.Ala499Ser | missense_variant | 9/20 | 1 | NM_015164.4 | ENSP00000364956.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 151732Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 6AN: 187862Hom.: 0 AF XY: 0.0000198 AC XY: 2AN XY: 101158
GnomAD4 exome AF: 0.0000232 AC: 33AN: 1423928Hom.: 0 Cov.: 33 AF XY: 0.0000156 AC XY: 11AN XY: 705008
GnomAD4 genome AF: 0.000191 AC: 29AN: 151732Hom.: 0 Cov.: 32 AF XY: 0.000203 AC XY: 15AN XY: 74052
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.1495G>T (p.A499S) alteration is located in exon 9 (coding exon 9) of the PLEKHM2 gene. This alteration results from a G to T substitution at nucleotide position 1495, causing the alanine (A) at amino acid position 499 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dilated Cardiomyopathy, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 499 of the PLEKHM2 protein (p.Ala499Ser). This variant is present in population databases (rs202014397, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PLEKHM2-related conditions. ClinVar contains an entry for this variant (Variation ID: 544347). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at